Literature DB >> 31378432

A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre- and postsynaptic defects of neuromuscular transmission.

Stefan Nicolau1, Teerin Liewluck1, Xin-Ming Shen1, Duygu Selcen1, Andrew G Engel1, Margherita Milone2.   

Abstract

Mutations in GMPPB cause a wide spectrum of neuromuscular syndromes, including muscular dystrophies and congenital myasthenic syndrome. The mechanisms by which GMPPB mutations impair neuromuscular transmission however remain incompletely understood. We expand here upon a previous report of one such patient presenting with a myopathy-congenital myasthenic syndrome overlap phenotype. Fatigable proximal muscle weakness developed gradually between 13 and 25 years of age, with subsequent stabilization. Low-frequency repetitive nerve stimulation showed a decrement, while a muscle biopsy demonstrated the presence of a centronuclear myopathy. Genetic testing identified a homozygous c.458C > T (p.Thr153Ile) variant in GMPPB. In-vitro microelectrode recordings and ultrastructural studies showed impairment of both pre- and postsynaptic neuromuscular transmission, thus demonstrating the presence of not only postsynaptic, but also presynaptic pathology in GMPPB-related disorders.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Centronuclear myopathy; Congenital myasthenic syndrome; GMPPB; Glycosylation; Neuromuscular junction

Year:  2019        PMID: 31378432      PMCID: PMC6897485          DOI: 10.1016/j.nmd.2019.07.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia.

Authors:  Teerin Liewluck; Xin-Ming Shen; Margherita Milone; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-04-08       Impact factor: 4.296

2.  Expanding the phenotype of GMPPB mutations.

Authors:  Macarena Cabrera-Serrano; Roula Ghaoui; Gianina Ravenscroft; Russell D Johnsen; Mark R Davis; Alastair Corbett; Stephen Reddel; Carolyn M Sue; Christina Liang; Leigh B Waddell; Simranpreet Kaur; Monkol Lek; Kathryn N North; Daniel G MacArthur; Phillipa J Lamont; Nigel F Clarke; Nigel G Laing
Journal:  Brain       Date:  2015-02-12       Impact factor: 13.501

3.  Two patients with GMPPB mutation: The overlapping phenotypes of limb-girdle myasthenic syndrome and limb-girdle muscular dystrophy dystroglycanopathy.

Authors:  Federica Montagnese; Elisabeth Klupp; Dimitrios C Karampinos; Saskia Biskup; Dieter Gläser; Jan S Kirschke; Benedikt Schoser
Journal:  Muscle Nerve       Date:  2017-02-23       Impact factor: 3.217

4.  A valid mouse model of AGRIN-associated congenital myasthenic syndrome.

Authors:  Laurent P Bogdanik; Robert W Burgess
Journal:  Hum Mol Genet       Date:  2011-09-01       Impact factor: 6.150

5.  Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.

Authors:  Mariko Taniguchi; Hiroki Kurahashi; Satoru Noguchi; Takayasu Fukudome; Takeshi Okinaga; Toshifumi Tsukahara; Youichi Tajima; Keiichi Ozono; Ichizo Nishino; Ikuya Nonaka; Tatsushi Toda
Journal:  Hum Mol Genet       Date:  2006-03-10       Impact factor: 6.150

6.  Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.

Authors:  Sophie Nicole; Amina Chaouch; Torberg Torbergsen; Stéphanie Bauché; Elodie de Bruyckere; Marie-Joséphine Fontenille; Morten A Horn; Marijke van Ghelue; Sissel Løseth; Yasmin Issop; Daniel Cox; Juliane S Müller; Teresinha Evangelista; Erik Stålberg; Christine Ioos; Annie Barois; Guy Brochier; Damien Sternberg; Emmanuel Fournier; Daniel Hantaï; Angela Abicht; Marina Dusl; Steven H Laval; Helen Griffin; Bruno Eymard; Hanns Lochmüller
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

7.  Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.

Authors:  Katsiaryna Belaya; Pedro M Rodríguez Cruz; Wei Wei Liu; Susan Maxwell; Simon McGowan; Maria E Farrugia; Richard Petty; Timothy J Walls; Maryam Sedghi; Keivan Basiri; Wyatt W Yue; Anna Sarkozy; Marta Bertoli; Matthew Pitt; Robin Kennett; Andrew Schaefer; Kate Bushby; Matt Parton; Hanns Lochmüller; Jacqueline Palace; Francesco Muntoni; David Beeson
Journal:  Brain       Date:  2015-06-30       Impact factor: 13.501

8.  Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases.

Authors:  Gaber Bergant; Ales Maver; Luca Lovrecic; Goran Čuturilo; Alenka Hodzic; Borut Peterlin
Journal:  Genet Med       Date:  2017-09-14       Impact factor: 8.822

9.  Clinical features of the myasthenic syndrome arising from mutations in GMPPB.

Authors:  Pedro M Rodríguez Cruz; Katsiaryna Belaya; Keivan Basiri; Maryam Sedghi; Maria Elena Farrugia; Janice L Holton; Wei Wei Liu; Susan Maxwell; Richard Petty; Timothy J Walls; Robin Kennett; Matthew Pitt; Anna Sarkozy; Matt Parton; Hanns Lochmüller; Francesco Muntoni; Jacqueline Palace; David Beeson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-05-04       Impact factor: 10.154

10.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.

Authors:  Keren J Carss; Elizabeth Stevens; A Reghan Foley; Sebahattin Cirak; Moniek Riemersma; Silvia Torelli; Alexander Hoischen; Tobias Willer; Monique van Scherpenzeel; Steven A Moore; Sonia Messina; Enrico Bertini; Carsten G Bönnemann; Jose E Abdenur; Carla M Grosmann; Akanchha Kesari; Jaya Punetha; Ros Quinlivan; Leigh B Waddell; Helen K Young; Elizabeth Wraige; Shu Yau; Lina Brodd; Lucy Feng; Caroline Sewry; Daniel G MacArthur; Kathryn N North; Eric Hoffman; Derek L Stemple; Matthew E Hurles; Hans van Bokhoven; Kevin P Campbell; Dirk J Lefeber; Yung-Yao Lin; Francesco Muntoni
Journal:  Am J Hum Genet       Date:  2013-06-13       Impact factor: 11.025

View more
  3 in total

1.  Congenital myasthenic syndrome in China: genetic and myopathological characterization.

Authors:  Yawen Zhao; Ying Li; Yang Bian; Sheng Yao; Penju Liu; Meng Yu; Wei Zhang; Zhaoxia Wang; Yun Yuan
Journal:  Ann Clin Transl Neurol       Date:  2021-03-23       Impact factor: 4.511

2.  A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.

Authors:  Kiran Polavarapu; Aradhna Mathur; Aditi Joshi; Saraswati Nashi; Veeramani Preethish-Kumar; Mainak Bardhan; Pooja Sharma; Shaista Parveen; Malika Seth; Seena Vengalil; Tanushree Chawla; Leena Shingavi; Uzma Shamim; Sushmita Nayak; A Vivekanand; Ana Töpf; Andreas Roos; Rita Horvath; Hanns Lochmüller; Bevinahalli Nandeesh; Gautham Arunachal; Atchayaram Nalini; Mohammed Faruq
Journal:  Neurogenetics       Date:  2021-08-01       Impact factor: 2.660

3.  Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP-predominant).

Authors:  Paloma Gonzalez-Perez; Cheryl Smith; Wendy L Sebetka; Amber Gedlinske; Seth Perlman; Katherine D Mathews
Journal:  Neuromuscul Disord       Date:  2020-01-25       Impact factor: 4.296

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.